LeonaBio (LONA) Assets (2019 - 2026)
LeonaBio (LONA) posted quarterly Assets of $71.6 million for Q1 2026, up 64.53% year-over-year from $43.5 million in Q1 2025, and down 22.31% quarter-over-quarter from $92.2 million in Q4 2025.
LeonaBio (LONA) Assets (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has reported Assets for 8 consecutive years, with $71.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 64.53% year-over-year to $71.6 million; the TTM figure through Mar 2026 stood at $71.6 million (up 64.53% YoY), while the FY2025 annual figure was $92.2 million, up 56.78% from the prior year.
- Assets retreated to $71.6 million in Q1 2026 per LONA's latest filing, from $92.2 million in the prior quarter.
- Across five years, Assets topped out at $313.0 million in Q1 2022 and bottomed at $30.0 million in Q3 2025.
- Historically, Assets has averaged $152.1 million across 5 years, with a median of $133.5 million in 2024.
- Annual changes were most pronounced in 2025 — Assets plunged 68.05% — and 2026, when it soared 64.53%.
- LeonaBio's Assets stood at $258.2 million in 2022, then slumped by 37.93% to $160.2 million in 2023, then sank by 63.32% to $58.8 million in 2024, then jumped by 56.78% to $92.2 million in 2025, then declined by 22.31% to $71.6 million in 2026.
- Business Quant data shows LONA's Assets at $71.6 million in Q1 2026, $92.2 million in Q4 2025, and $30.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | LeonaBio | 180.91 Mn | 129.85 Mn | - | 56.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.59 Mn |
| Dec 31, 2025 | 92.15 Mn |
| Sep 30, 2025 | 30.03 Mn |
| Jun 30, 2025 | 35.55 Mn |
| Mar 31, 2025 | 43.51 Mn |
| Dec 31, 2024 | 58.78 Mn |
| Sep 30, 2024 | 86.25 Mn |
| Jun 30, 2024 | 111.25 Mn |
| Mar 31, 2024 | 133.46 Mn |
| Dec 31, 2023 | 160.25 Mn |
| Sep 30, 2023 | 184.70 Mn |
| Jun 30, 2023 | 208.05 Mn |
| Mar 31, 2023 | 232.77 Mn |
| Dec 31, 2022 | 258.15 Mn |
| Sep 30, 2022 | 274.19 Mn |
| Jun 30, 2022 | 292.01 Mn |
| Mar 31, 2022 | 313.00 Mn |
| Dec 31, 2021 | 332.01 Mn |
| Sep 30, 2021 | 347.33 Mn |
| Jun 30, 2021 | 360.12 Mn |